Idiopathic calcitriol-induced hypercalcemia.
Rijckborst
V
V
Department of Internal Medicine, Amphia Hospital, Breda, The Netherlands.
van Wijngaarden
P
P
D000368:Aged; D050071:Bone Density Conservation Agents / Q000627:therapeutic use; D002117:Calcitriol / Q000009:adverse effects* / Q000096:biosynthesis; D004164:Diphosphonates / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D006934:Hypercalcemia / Q000139:chemically induced*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D016896:Treatment Outcome
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D002117:Calcitriol; D011241:Prednisone